Digestive Diseases and Sciences

, Volume 54, Issue 6, pp 1199–1202 | Cite as

Management of Severe Clostridium difficile-Associated Diarrhea

  • Michael J. Krier
  • George Triadafilopoulos
Stanford Multidisciplinary Seminars

Presentation and Evolution of Two Cases

First Patient

An 84-year-old woman was brought to the emergency department by paramedics because of weakness and near syncope after several days of severe abdominal cramps and watery diarrhea, reduced oral intake, and progressive orthostatic dizziness. The patient had been discharged from the hospital 10 days ago, after successful treatment of pneumonia with broad-spectrum antibiotics. Her past medical history consisted of chronic interstitial lung disease, pulmonary hypertension, and bilateral mastectomies for breast cancer. Because of increasingly severe and diffuse abdominal pain, dyspnea, septic shock, and eventually respiratory failure, she was intubated and admitted to the intensive care unit where she had a fever of 100.5°F, pulse 110, and blood pressure 110/35 mmHg on low-level vasoactive medications. Her examination revealed decreased breath sounds bilaterally and a diffusely tender and distended abdomen with hypoactive bowel sounds....


Vancomycin Metronidazole Interstitial Lung Disease Percutaneous Endoscopic Gastrostomy Pseudomembranous Colitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Blossom DB, McDonald LC. The challenges posed by re-emerging Clostridium difficile infection. Clin Infect Dis. 2007;45:222–227. doi: 10.1086/518874.PubMedCrossRefGoogle Scholar
  2. 2.
    Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(6):2–18. doi: 10.1111/j.1469-0691.2006.01580.x.PubMedCrossRefGoogle Scholar
  3. 3.
    Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–2449. doi: 10.1056/NEJMoa051639.PubMedCrossRefGoogle Scholar
  4. 4.
    Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg. 1995;169:480–483. doi: 10.1016/S0002-9610(99)80199-8.PubMedCrossRefGoogle Scholar
  5. 5.
    Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum. 1995;38:350–354. doi: 10.1007/BF02054220.PubMedCrossRefGoogle Scholar
  6. 6.
    Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol. 2002;23:137–140. doi: 10.1086/502023.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuijper EJ, van Dissel JT, Wilcox MH. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis. 2007;20:376–383.PubMedGoogle Scholar
  8. 8.
    Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–1084. doi: 10.1016/S0140-6736(05)67420-X.PubMedCrossRefGoogle Scholar
  9. 9.
    Cloud J, Kelly CP. Update on Clostridium difficile associated disease. Curr Opin Gastroenterol. 2007;23:4–9.PubMedGoogle Scholar
  10. 10.
    Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359:1932–1940. doi: 10.1056/NEJMra0707500.PubMedCrossRefGoogle Scholar
  11. 11.
    Belmares J, Gerding DN, Parada JP, Miskevics S, Weaver F, Johnson S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect. 2007;55:495–501.PubMedGoogle Scholar
  12. 12.
    Morris JB, Zollinger RM Jr, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg. 1990;160:535–539. doi: 10.1016/S0002-9610(05)81024-4.PubMedCrossRefGoogle Scholar
  13. 13.
    Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363–372. doi: 10.1097/00000658-200203000-00008.PubMedCrossRefGoogle Scholar
  14. 14.
    Klipfel A, Schein M, Fahoum B, et al. Acute abdomen, Clostridium difficile colitis: still a lethal combination. Dig Surg. 2000;17:160–163. doi: 10.1159/000018821.PubMedCrossRefGoogle Scholar
  15. 15.
    Synnott K, Mealy K, Merry C, et al. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg. 1998;85:229–231. doi: 10.1046/j.1365-2168.1998.00519.x.PubMedCrossRefGoogle Scholar
  16. 16.
    Shetler K, Nieuwenhuis R, Wren SM, Triadafilopoulos G. Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis. Surg Endosc. 2001;15:653–659. doi: 10.1007/s004640080104.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyStanford University Medical CenterStanfordUSA

Personalised recommendations